<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary splenic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is rare, but malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> often produces a lesion in the spleen as part of <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The frequency of splenic malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Japan is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We classified 184 specimens of the spleen according to the World Health Organization Classification of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumours</z:e> of Haematopoietic and Lymphoid Tissues, 4th edition (2008) </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 184 specimens, 115 were determined to be lymphoid <z:hpo ids='HP_0002664'>neoplasm</z:hpo> (62.5%) </plain></SENT>
<SENT sid="4" pm="."><plain>The most common subtype of lymphoid <z:hpo ids='HP_0002664'>neoplasm</z:hpo> was diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) (46 cases), followed by splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>) (28 cases), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (11 cases), splenic B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, unclassifiable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SBL</z:e>-U) (6 cases) and peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, not otherwise specified (4 cases) </plain></SENT>
<SENT sid="5" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SBL</z:e>-U subtype, 5 of 6 cases were splenic diffuse red pulp small B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and one case was the hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> variant </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of clinical features revealed that patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> had a higher age, high <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation in the spleen </plain></SENT>
<SENT sid="7" pm="."><plain>On the other hand, it was found that patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> had <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> but no discrete <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation </plain></SENT>
<SENT sid="8" pm="."><plain>Most of the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SBL</z:e>-U presented with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, bone marrow involvement, and advanced stage </plain></SENT>
<SENT sid="9" pm="."><plain>Our study revealed the frequency and clinical features of splenic malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Japan </plain></SENT>
</text></document>